Pharmacy

A recent blog post by LogicStream dives into hospital pharmacy trends in 2019. 

Below are eight legal actions involving members of the drug supply chain, including pharmaceutical companies, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

McKesson has renewed its distribution agreement with its largest client, CVS Health, the drug distributor announced during its earnings call May 9, according to Reuters.

A generic version of Gilead Sciences' HIV prevention drug, Truvada, will be available one year earlier than expected due to an agreement struck with Teva Pharmaceuticals a few years ago, the drugmaker announced May 8, according to CNBC.

Joining a growing list of retailers, Walmart will increase the minimum age to buy tobacco products to 21, according to CNBC.

Shire's hereditary angioedema drug Takhzyro tops GoodRx's list of the most expensive drugs approved in the U.S. last year, with a list price of $573,820 per year.

HHS finalized a rule May 8 requiring drugmakers to include the list price of prescription drugs in direct-to-consumer TV ads, Reuters reports.

The Sacklers, the billionaire family that owns Purdue Pharma, discussed selling the company in 2000, the Wall Street Journal reports, citing court documents made public May 7.

Nostrum Laboratories, a drugmaker based in Kansas City, Mo., raised the price of its prescription cold remedy by 326 percent at the end of April, according to the Financial Times.

Johnson & Johnson has agreed to pay about $1 billion to resolve the bulk of the lawsuits alleging it sold defective metal-on-metal hip implants, according to Bloomberg.